14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $141.16 $183.01 Monday, 6th May 2024 ZNTL stock ended at $11.72. This is 0.0854% more than the trading day before Friday, 3rd May 2024. During the day the stock fluctuated 5.63% from a day low at $11.55 to a day high of $12.20.
90 days $141.16 $227.30
52 weeks $84.73 $227.30

Historical Zentalis Pharmaceuticals Inc. prices

Date Open High Low Close Volume
May 14, 2020 $36.87 $38.97 $35.17 $37.96 139 014
May 13, 2020 $36.07 $38.99 $34.96 $36.50 273 985
May 12, 2020 $34.70 $37.13 $34.55 $35.64 172 319
May 11, 2020 $32.63 $38.03 $32.63 $34.50 325 628
May 08, 2020 $32.15 $33.82 $31.82 $33.27 124 931
May 07, 2020 $32.98 $34.31 $31.50 $31.93 253 523
May 06, 2020 $33.63 $33.63 $31.26 $32.98 230 081
May 05, 2020 $31.21 $34.57 $30.28 $33.26 192 100
May 04, 2020 $30.56 $31.97 $28.01 $31.93 161 304
May 01, 2020 $34.33 $35.39 $30.77 $31.29 318 034
Apr 30, 2020 $35.57 $36.50 $34.28 $35.10 233 948
Apr 29, 2020 $36.42 $37.43 $35.30 $36.16 187 598
Apr 28, 2020 $33.72 $35.57 $32.17 $35.57 198 673
Apr 27, 2020 $31.00 $32.80 $30.70 $31.76 89 372
Apr 24, 2020 $28.51 $30.78 $28.30 $30.50 155 226
Apr 23, 2020 $26.59 $29.33 $26.02 $28.45 110 681
Apr 22, 2020 $25.82 $27.00 $25.00 $26.79 117 956
Apr 21, 2020 $24.39 $25.73 $23.50 $25.56 259 794
Apr 20, 2020 $24.61 $25.30 $24.04 $24.12 529 724
Apr 17, 2020 $24.40 $25.44 $24.13 $24.56 264 285
Apr 16, 2020 $24.48 $25.84 $24.00 $24.38 131 013
Apr 15, 2020 $24.89 $25.84 $23.90 $24.48 205 471
Apr 14, 2020 $24.04 $26.39 $23.28 $25.12 238 193
Apr 13, 2020 $24.50 $25.10 $23.81 $23.90 88 741
Apr 09, 2020 $25.25 $26.34 $24.25 $24.31 69 721
Click to get the best stock tips daily for free!

About Zentalis Pharmaceuticals Inc.

Zentalis Pharmaceuticals. Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatment of various cancers. Its lead product candidate includes the ZN-c3, an inhibitor of WEE1, a protein tyrosine kinase, which is in Phase 2 clinical trial for the treatment of advanced solid tumors; Phase 1/2 clinical trial for the treatment of advanced solid tumors as a monotherapy and in an ... ZNTL Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT